John G Doench, Age 4636 Robinwood Ave APT 3, Boston, MA 02130

John Doench Phones & Addresses

36 Robinwood Ave APT 3, Jamaica Plain, MA 02130

Boston, MA

Cresskill, NJ

Cambridge, MA

116 Holland St, Somerville, MA 02144 (617) 764-1476

56 Gorham St, Somerville, MA 02144 (617) 764-1476

Clinton, NY

Show more

Mentions for John G Doench

John Doench resumes & CV records

Resumes

John Doench Photo 13

Institute Scientist

Location:
415 Main St, Cambridge, MA 02142
Industry:
Research
Work:
Broad Institute since Nov 2009
Research Scientist
Harvard Medical School Sep 2005 - Nov 2009
Postdoctoral Fellow
M.I.T. Koch Institute for Integrative Cancer Reserach 2000 - 2005
Graduate Student
Education:
Massachusetts Institute of Technology 2000 - 2005
PhD, Biology
Hamilton College 1996 - 2000
BA, Biochemistry, History
Skills:
Molecular Biology, Cell Biology, Biochemistry, Cell Culture, Genetics, Genomics, Pcr, Bioinformatics, Biotechnology, Lifesciences, Cancer, Molecular Cloning, Cell, Drug Discovery, Neuroscience, Protein Expression, Oncology, Assay Development, Immunology, Western Blotting
John Doench Photo 14

John Doench

Publications & IP owners

Us Patents

Reagents And Methods For Identification Of Rnai Pathway Genes And Chemical Modulators Of Rnai

US Patent:
2005026, Dec 1, 2005
Filed:
Dec 5, 2004
Appl. No.:
11/005127
Inventors:
John Doench - Somerville MA, US
Derek Dykxhoorn - Watertown MA, US
Carl Novina - Newton MA, US
Phillip Sharp - Newton MA, US
International Classification:
C12P021/06
C12N005/06
C12N005/08
C12N015/85
US Classification:
435358000, 435455000, 435367000
Abstract:
The present invention provides reagents such as cells, cell lines, and vectors, that can be used to identify mammalian genes whose expression products (RNA or protein) play a role in RNA interference (RNAi) and/or to identify chemical modulators of RNAi, or for other purposes. The invention further provides a variety of methods for identifying such genes or modulators. In particular, the invention provides a mammalian cell comprising a nucleic acid that encodes a selectable marker and one or more nucleic acid templates for transcription of an RNAi-inducing agent integrated into the genome of the cell, wherein the RNAi-inducing agent reduces expression of the marker and is not naturally found in the cell. Additional cells and cell lines comprising nucleic acids that encode one or more additional markers are also provided. According to certain of the inventive methods cells such as these are mutagenized, transfected or infected with a library of genetic suppressor elements, or contacted with a test compound. Cells in which RNAi is inhibited or activated are identified using an appropriate selective condition or screening method. The identity of the mutated or inhibited gene or the identity of the compound is then determined.

Functional Genomics Using Crispr-Cas Systems, Compositions, Methods, Screens And Applications Thereof

US Patent:
2021010, Apr 15, 2021
Filed:
Sep 21, 2020
Appl. No.:
17/027151
Inventors:
- Cambridge MA, US
Neville Espi SANJANA - Cambridge MA, US
John DOENCH - Cambridge MA, US
David ROOT - Cambridge MA, US
Ella Nicole BIEWENER HARTENIAN - Cambridge MA, US
Assignee:
The Broad Institute, Inc. - Cambridge MA
Massachusetts Institute of Technology - Cambridge MA
International Classification:
C12N 15/10
C12N 15/63
C12N 9/22
C12N 15/90
Abstract:
The present invention generally relates to libraries, compositions, methods, applications, kits and screens used in functional genomics that focus on gene function in a cell and that may use vector systems and other aspects related to Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas systems and components thereof. Provided are vectors and vector systems, some of which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods of directing CRISPR complex formation in eukaryotic cells and methods for utilizing the CRISPR-Cas system.

Methods And Compositions For Massively Parallel Variant And Small Molecule Phenotyping

US Patent:
2020028, Sep 10, 2020
Filed:
Mar 4, 2020
Appl. No.:
16/809458
Inventors:
- Cambridge MA, US
John Doench - Cambridge MA, US
JT Neal - Cambridge MA, US
Jesse Boehm - Cambridge MA, US
Oana Ursu - Cambridge MA, US
International Classification:
C12Q 1/6869
C12N 15/10
Abstract:
The present invention provides methods and tools for analyzing genetic interactions. The subject matter is generally directed to single-cell genomics and proteomics, including methods of performing genome-wide CRISPR perturbation screens and determining gene expression phenotypes.

Functional Genomics Using Crispr-Cas Systems, Compositions, Methods, Screens And Applications Thereof

US Patent:
2016027, Sep 22, 2016
Filed:
Dec 17, 2015
Appl. No.:
14/973062
Inventors:
- Cambridge MA, US
Neville Espi Sanjana - Cambridge MA, US
John Doench - Boston MA, US
David Root - Brookline MA, US
Ella Nicole Biewener Hartenian - Brookline MA, US
International Classification:
C12N 15/10
C12N 15/90
Abstract:
The present invention generally relates to libraries, compositions, methods, applications, kits and screens used in functional genomics that focus on gene function in a cell and that may use vector systems and other aspects related to Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas systems and components thereof. Provided are vectors and vector systems, some of which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods of directing CRISPR complex formation in eukaryotic cells and methods for utilizing the CRISPR-Cas system.

Public records

Vehicle Records

John Doench

Address:
36 Robinwood Ave APT 3, Boston, MA 02130
VIN:
JTDBL40E799080747
Make:
TOYOTA
Model:
COROLLA
Year:
2009

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.